Skip to main content
Top
Published in: Annals of Nuclear Medicine 7/2016

01-08-2016 | Short Communication

FDG-PET characteristics of Hürthle cell and follicular adenomas

Authors: Kumar Alok Pathak, Thomas Klonisch, Richard W. Nason, William D. Leslie

Published in: Annals of Nuclear Medicine | Issue 7/2016

Login to get access

Abstract

Objective

Follicular (FN) and Hürthle cell neoplasms (HCN) are considered indeterminate on thyroid fine needle aspiration cytology and are preoperative diagnostic challenges. The role of [18F]-2-fluoro-2-deoxy-d-glucose (FDG) in characterizing indeterminate thyroid nodules remains equivocal, because of the increased FDG uptake by some benign thyroid nodules. The objective of this study was to compare the FDG positron emission tomography/computerized tomography (PET/CT) characteristics of follicular (FA) and Hürthle cell adenomas (HCA).

Methods

Twenty-nine patients with 31 thyroid nodules underwent FDG-PET/CT scans of the neck and superior mediastinum for indeterminate FN/HCN, and were later found to have benign adenomas on final histopathology. All scans were reported by a single observer, who was blinded to the surgical and pathology findings. Receiver operating characteristic (ROC) curve analysis of maximum standardized uptake value (SUVmax) and the area under the curve (AUROC) were used to assess discrimination between FA and HCA. Youden index was used to identify the optimal cut-off SUVmax. Sensitivity, specificity, predictive values and overall accuracy were used as measures of performance.

Results

The mean age of our study cohort was 60.7 ± 12.6 years and 77 % of the patients were females. Age of the patients (p = 0.48), their gender (p = 0.52), and the size of thyroid nodules (p = 0.79) were similar for FA and HCA. Increased focal FDG uptake was observed in 100 % of HCA and 52 % of FA (p = 0.02). SUVmax of HCA was significantly higher (p < 0.001) than that of FA. SUVmax of 5 was the best cut-off for discrimination between HCA and FA, with AUROC of 0.90 (95 % CI, 0.79–1.00; p = 0.001). With this cut-off, FDG-PET/CT had sensitivity of identifying HCA of 88 % (95 % CI 47–99 %), specificity of 87 % (95 % CI 65–97 %), positive predictive value of 70 % (95 % CI 35–92 %), and negative predictive value of 95 % (95 % CI 74–99 %). The overall accuracy was 87 %.

Conclusions

HCA shows significantly higher focal FDG uptake as compared to FA and should always be considered in the differential diagnosis of FDG-PET positive thyroid nodules.
Literature
1.
go back to reference Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology: current status. CA Cancer J Clin. 2009;59:99–110.CrossRefPubMed Layfield LJ, Cibas ES, Gharib H, Mandel SJ. Thyroid aspiration cytology: current status. CA Cancer J Clin. 2009;59:99–110.CrossRefPubMed
2.
go back to reference Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.CrossRefPubMed Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19:1159–65.CrossRefPubMed
3.
go back to reference Zandieh S, Pokieser W, Knoll P, Sonneck-Koenne C, Kudlacek M, Mirzaei S. Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan. Acta Radiol. 2015;56:709–13.CrossRefPubMed Zandieh S, Pokieser W, Knoll P, Sonneck-Koenne C, Kudlacek M, Mirzaei S. Oncocytic adenomas of thyroid-mimicking benign or metastatic disease on 18F-FDG-PET scan. Acta Radiol. 2015;56:709–13.CrossRefPubMed
4.
go back to reference Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hurthle cell tumor of the thyroid. Eur Radiol. 1999;9:975–8.CrossRefPubMed Wiesner W, Engel H, von Schulthess GK, Krestin GP, Bicik I. FDG PET-negative liver metastases of a malignant melanoma and FDG PET-positive Hurthle cell tumor of the thyroid. Eur Radiol. 1999;9:975–8.CrossRefPubMed
5.
go back to reference Grant CS, Barr D, Goellner JR, Hay ID. Benign Hurthle cell tumors of the thyroid: a diagnosis to be trusted? World J Surg. 1988;12:488–95.CrossRefPubMed Grant CS, Barr D, Goellner JR, Hay ID. Benign Hurthle cell tumors of the thyroid: a diagnosis to be trusted? World J Surg. 1988;12:488–95.CrossRefPubMed
6.
go back to reference Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139:555–60.PubMed Thompson NW, Dunn EL, Batsakis JG, Nishiyama RH. Hurthle cell lesions of the thyroid gland. Surg Gynecol Obstet. 1974;139:555–60.PubMed
7.
go back to reference McLeod MK, Thompson NW, Hudson JL, Gaglio JA, Lloyd RV, Harness JK, et al. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hurthle cell neoplasms of the thyroid. Arch Surg. 1988;123:849–54.CrossRefPubMed McLeod MK, Thompson NW, Hudson JL, Gaglio JA, Lloyd RV, Harness JK, et al. Flow cytometric measurements of nuclear DNA and ploidy analysis in Hurthle cell neoplasms of the thyroid. Arch Surg. 1988;123:849–54.CrossRefPubMed
8.
go back to reference Bybel B, Greenberg ID, Paterson J, Ducharme J, Leslie WD. Increased F-18 FDG intestinal uptake in diabetic patients on metformin: a matched case-control analysis. Clin Nucl Med. 2011;36:452–6.CrossRefPubMed Bybel B, Greenberg ID, Paterson J, Ducharme J, Leslie WD. Increased F-18 FDG intestinal uptake in diabetic patients on metformin: a matched case-control analysis. Clin Nucl Med. 2011;36:452–6.CrossRefPubMed
9.
go back to reference Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47:458–72.CrossRefPubMed Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47:458–72.CrossRefPubMed
10.
go back to reference Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital. 2009;29:305–11.PubMedPubMedCentral Barnabei A, Ferretti E, Baldelli R, Procaccini A, Spriano G, Appetecchia M. Hurthle cell tumours of the thyroid. Personal experience and review of the literature. Acta Otorhinolaryngol Ital. 2009;29:305–11.PubMedPubMedCentral
11.
go back to reference Maximo V, Sobrinho-Simoes M. Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch. 2000;437:107–15.CrossRefPubMed Maximo V, Sobrinho-Simoes M. Hurthle cell tumours of the thyroid. A review with emphasis on mitochondrial abnormalities with clinical relevance. Virchows Arch. 2000;437:107–15.CrossRefPubMed
12.
go back to reference Paul A, Villepelet A, Lefevre M, Perie S. Oncocytic parathyroid adenoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:301–3.CrossRefPubMed Paul A, Villepelet A, Lefevre M, Perie S. Oncocytic parathyroid adenoma. Eur Ann Otorhinolaryngol Head Neck Dis. 2015;132:301–3.CrossRefPubMed
13.
14.
go back to reference Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer. 1989;64:1888–93.CrossRefPubMed Bisi H, Fernandes VS, de Camargo RY, Koch L, Abdo AH, de Brito T. The prevalence of unsuspected thyroid pathology in 300 sequential autopsies, with special reference to the incidental carcinoma. Cancer. 1989;64:1888–93.CrossRefPubMed
15.
go back to reference Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L. Focal thyroid incidental uptake detected by (1)(8)F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk. Nuklearmedizin. 2013;52:130–6.CrossRefPubMed Treglia G, Bertagna F, Sadeghi R, Verburg FA, Ceriani L, Giovanella L. Focal thyroid incidental uptake detected by (1)(8)F-fluorodeoxyglucose positron emission tomography. Meta-analysis on prevalence and malignancy risk. Nuklearmedizin. 2013;52:130–6.CrossRefPubMed
16.
go back to reference Kim H, Kim SJ, Kim IJ, Kim K. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer—a large retrospective monocentric study. Onkologie. 2013;36:260–4.CrossRefPubMed Kim H, Kim SJ, Kim IJ, Kim K. Thyroid incidentalomas on FDG PET/CT in patients with non-thyroid cancer—a large retrospective monocentric study. Onkologie. 2013;36:260–4.CrossRefPubMed
17.
go back to reference Pagano L, Sama MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by (1)(8)F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75:528–34.CrossRef Pagano L, Sama MT, Morani F, Prodam F, Rudoni M, Boldorini R, et al. Thyroid incidentaloma identified by (1)(8)F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance. Clin Endocrinol (Oxf). 2011;75:528–34.CrossRef
18.
go back to reference Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine. 2013;43:678–85.CrossRefPubMed Bertagna F, Treglia G, Piccardo A, Giovannini E, Bosio G, Biasiotto G, et al. F18-FDG-PET/CT thyroid incidentalomas: a wide retrospective analysis in three Italian centres on the significance of focal uptake and SUV value. Endocrine. 2013;43:678–85.CrossRefPubMed
19.
go back to reference de Geus-Oei LF, Pieters GF, Bonenkamp JJ, Mudde AH, Bleeker-Rovers CP, Corstens FH, et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nuclear Med. 2006;47:770–5. de Geus-Oei LF, Pieters GF, Bonenkamp JJ, Mudde AH, Bleeker-Rovers CP, Corstens FH, et al. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results. J Nuclear Med. 2006;47:770–5.
20.
go back to reference Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, et al. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012;22:165–72.CrossRefPubMed Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, et al. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology? Thyroid. 2012;22:165–72.CrossRefPubMed
21.
go back to reference Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008;29:113–8.CrossRefPubMed Hales NW, Krempl GA, Medina JE. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules? Am J Otolaryngol. 2008;29:113–8.CrossRefPubMed
22.
go back to reference Kim JM, Ryu JS, Kim TY, Kim WB, Kwon GY, Gong G, et al. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab. 2007;92:1630–4.CrossRefPubMed Kim JM, Ryu JS, Kim TY, Kim WB, Kwon GY, Gong G, et al. 18F-fluorodeoxyglucose positron emission tomography does not predict malignancy in thyroid nodules cytologically diagnosed as follicular neoplasm. J Clin Endocrinol Metab. 2007;92:1630–4.CrossRefPubMed
23.
go back to reference Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294–9.CrossRefPubMed Kresnik E, Gallowitsch HJ, Mikosch P, Stettner H, Igerc I, Gomez I, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area. Surgery. 2003;133:294–9.CrossRefPubMed
24.
go back to reference Smith RB, Robinson RA, Hoffman HT, Graham MM. Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngol Head Neck Surg. 2008;138:101–6.CrossRefPubMed Smith RB, Robinson RA, Hoffman HT, Graham MM. Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid. Otolaryngol Head Neck Surg. 2008;138:101–6.CrossRefPubMed
25.
go back to reference Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, et al. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg. 2010;34:1247–53.CrossRefPubMedPubMedCentral Traugott AL, Dehdashti F, Trinkaus K, Cohen M, Fialkowski E, Quayle F, et al. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis. World J Surg. 2010;34:1247–53.CrossRefPubMedPubMedCentral
26.
go back to reference Sebastianes FM, Cerci JJ, Zanoni PH, Soares J Jr, Chibana LK, Tomimori EK, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2007;92:4485–8.CrossRefPubMed Sebastianes FM, Cerci JJ, Zanoni PH, Soares J Jr, Chibana LK, Tomimori EK, et al. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules. J Clin Endocrinol Metab. 2007;92:4485–8.CrossRefPubMed
27.
go back to reference Wang N, Zhai H, Lu Y. Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J Otolaryngol Head Neck Surg. 2013;42:38.CrossRefPubMedPubMedCentral Wang N, Zhai H, Lu Y. Is fluorine-18 fluorodeoxyglucose positron emission tomography useful for the thyroid nodules with indeterminate fine needle aspiration biopsy? A meta-analysis of the literature. J Otolaryngol Head Neck Surg. 2013;42:38.CrossRefPubMedPubMedCentral
28.
go back to reference Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582–94.CrossRefPubMed Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [18F]-2-fluoro-2-deoxy-d-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582–94.CrossRefPubMed
Metadata
Title
FDG-PET characteristics of Hürthle cell and follicular adenomas
Authors
Kumar Alok Pathak
Thomas Klonisch
Richard W. Nason
William D. Leslie
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 7/2016
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-016-1087-6

Other articles of this Issue 7/2016

Annals of Nuclear Medicine 7/2016 Go to the issue